Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief
Dane D. Jensen(Australian Research Council), Nigel W. Bunnett(New York University), Carmen Klein Herenbrink(Australian Research Council), TinaMarie Lieu(Sage Therapeutics (United States)), Daniel P. Poole(Monash University), Michelle L. Halls(Discovery Institute), Nicholas A. Veldhuis(Australian Research Council), Adam McCluskey(University of Newcastle Australia), MacDonald J. Christie(The University of Sydney), Christopher J. H. Porter(Monash University), Jamie S. Simpson(University of Michigan), Joshua Conner(Australian Research Council), M.J. Scanlon(Monash University), Νicholas Barlow(Monash University), Meritxell Canals(University of Nottingham), Romina Nassini(University of Florence), Wendy L. Imlach(Australian Regenerative Medicine Institute), Tim Quach(Australian Research Council), Serena Materazzi(University of Florence), Gareth A. Hicks(Takeda (Japan)), Virginie Escriou(Centre National de la Recherche Scientifique), Luigi Aurelio(Australian Research Council), Pierangelo Geppetti(University of Florence), Bimbil Graham(Monash University), Phillip J. Robinson(Canterbury Christ Church University)
Cited by 240
Related Papers
Cloning and expression of a rat D2 dopamine receptor cDNA
|Nature|1988|1.1k
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
|Proceedings of the National Academy of Sciences|2002|963
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
|Nature Medicine|2000|931
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.
|Journal of Clinical Investigation|1994|863
Mast Cell-Dependent Excitation of Visceral-Nociceptive Sensory Neurons in Irritable Bowel Syndrome
|Gastroenterology|2007|768